Endocrine Abstracts

Introduction: Extended Forsteo® Observational Study (ExFOS), a multinational, non-interventional, prospective, observational study, designed to evaluate fractures, back pain (BP), adherence and health-related quality of life (QoL) in teriparatide (TPTD) treated patients, based on the extension of treatment duration (24 months) and the addition of new indications (glucocorticoid-induced and male osteoporosis) was compared with EFOS.Methods...

Introduction: ExFOS is a multinational, non-interventional, prospective, observational study to evaluate fracture outcomes, back pain, compliance and health-related quality of life in osteoporotic patients treated with teriparatide for up to 24 months. We present the baseline characteristics of the Hellenic subpopulation.Methods: In Greece, 439 consenting patients with osteoporosis (92.3% females), suitable for prescribing teriparatide in the course of n...

Purpose: Extended Forsteo Observational Study (ExFOS), a multinational, non-interventional, prospective, observational study to evaluate fracture outcomes, back pain, compliance and health-related quality of life in osteoporotic male and female patients treated with teriparatide (TPTD), has followed European Forsteo Observational Study (EFOS) on postmenopausal women, aiming to provide more data on the effect of the extension of treatment duration from 18 to 24 months and the n...

Aim: The Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS) is an open-label multinational observational study which collects information on management, clinical outcomes and treatment safety of children with growth disorders. Here we present descriptive data from the Greek cohort.Methods and results: In Greece, 211 children (44.5% females, 136 naive to GH treatment at study entry and 18 not GH-treated) have been enrolled, aft...